Endo Health Solutions Lowered to Sell at Cantor Fitzgerald (ENDP)
Endo Health Solutions (NASDAQ:ENDP) was downgraded by stock analysts at Cantor Fitzgerald from a “hold” rating to a “sell” rating in a report issued on Thursday, TheFlyOnTheWall.com reports.
Shares of Endo Health Solutions (NASDAQ:ENDP) opened at 67.46 on Thursday. Endo Health Solutions has a 52 week low of $25.01 and a 52 week high of $67.63. The stock’s 50-day moving average is $65.75 and its 200-day moving average is $47.85. The company’s market cap is $7.750 billion.
Endo Health Solutions (NASDAQ:ENDP) last announced its earnings results on Thursday, November 7th. The company reported $1.34 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.11 by $0.23. The company had revenue of $715.00 million for the quarter, compared to the consensus estimate of $695.63 million. During the same quarter in the previous year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was down 4.7% on a year-over-year basis. On average, analysts predict that Endo Health Solutions will post $4.77 earnings per share for the current fiscal year.
ENDP has been the subject of a number of other recent research reports. Analysts at Goldman Sachs Group Inc. raised their price target on shares of Endo Health Solutions from $65.00 to $75.00 in a research note to investors on Monday, December 16th. They now have a “buy” rating on the stock. Separately, analysts at Zacks downgraded shares of Endo Health Solutions from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, November 27th. They now have a $70.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Endo Health Solutions in a research note to investors on Tuesday, November 12th. They now have a $70.00 price target on the stock, up previously from $43.00. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $51.87.
Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.